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ABSTRACT
Objectives. The aim of the study was to describe the adherence of Finnish people with glaucoma to 
prescribed treatment plans, the factors connected to adherence and to produce knowledge for devel-
oping effective interventions to improve adherence to treatment plans. 
Study design. This was a cross-sectional study.
Methods. The data (n=249) were collected at one point in time from Finnish adults diagnosed with 
glaucoma with a questionnaire covering adherence to treatment.  These patients used glaucoma medi-
cation and had follow-up appointments with ophthalmologists. 
Results. Sixty-seven percent (n=166) of the patients with glaucoma were very adherent to the prescribed 
treatment plan in terms of self-care, treatment and follow-up visits. Almost all were very adherent to 
medical care (97%, n=242). More than half of those who had received information from physicians 
and nurses were very adherent to treatment (66%, n=163). Two factors, support from physicians and 
nurses (p<0.001) and being informed of the consequences of treatments (p=0.003), had a statistically 
significant connection to treatment adherence. 
Conclusions. This study indicates that people with glaucoma in Finland adhere well to care and excep-
tionally well to medical care. Support and patient education from health care personnel is crucial to 
maintain patient adherence to treatment. These results indicate that nurses play a very important role 
in patient education and support. In practice, it is crucial to maintain this level of patient engagement 
by developing more tailored and time-saving education and support methods. The results of this 
study could be helpful for developing new patient education and support approaches for people with 
glaucoma.
(Int J Circumpolar Health 2011; 70(1):79–89)
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INTRODUCTION
Glaucoma is a chronic ophthalmic illness. It is a 
progressive neuropathy of the optic nerve which 
results in typical structural and functional abnor-
malities in the visual field. One of its symptoms 
is increased intra-ocular pressure. In the majority 
of the cases, abnormalities progress slowly and 
occur at the initial stages of the illness (1). The 
treatment of glaucoma comprises medication, 
laser treatment and surgical procedures (2). The 
aim of the treatment is to prevent visual impair-
ment by lowering the intra-ocular pressure. The 
initial treatment is usually eyedrops. People with 
glaucoma should visit their ophthalmologist 
every 6–12 months (3)
For people with glaucoma, fear of vision loss 
is very common; one-third of patients with glau-
coma in Norway were afraid of vision loss, and 
80% had some negative feelings during the early 
stages of their illness (4). Almost half (25–43%) 
had suffered side effects from prescribed medi-
cation(4–6), such as allergic reactions, itching, 
tearing, foggy vision, headache, bitter taste, 
arrhythmia, tiredness and nausea (3,4). However, 
people with glaucoma living in Sweden generally 
felt their health-related quality of life was good 
(7).
There are 5.3 million people in Finland and 
about 650,000 (12%) of them live in the northern 
part of the country (8). According to the latest 
Finnish Register of Visual Impairment, 80,000 
people in the country live with visual impair-
ment, 6.4% of which is caused by glaucoma. 
The prevalence (age- and gender-standardized) 
for 10,000 people is 33.5. The prevalence is high 
in the Lapland area (47) as well as in the Oulu 
UCH area (39.8). In the Helsinki UCH area, the 
prevalence is 27.7. (9) During 2008, over 76,000 
people were entitled to reimbursement for glau-
coma medicines in Finland, with 11% of these 
living in northern Finland (10). In the past, it has 
been estimated that by the year 2010, there could 
be 60 million people living with glaucoma, and 
it could be the second leading cause of blindness 
worldwide. The number of people with glaucoma 
in Europe could be 12 million by the year 2010 
and 13.9 million by the year 2020 (11). 
The problem of getting people with glau-
coma to maintain their treatment regimen is 
common in all parts of Finland, as is also the case 
in Norway (4). The illness requires patients to 
regularly visit an ophthalmologist and undergo 
follow-up inspections. Access to this care may 
be challenging, especially in northern Finland, 
where distances are great and the number of 
ophthalmologists is lower than in southern parts 
of the country. People have to take responsibility 
for their own care and follow-up visits. This is 
why it is very important for people with glaucoma 
to adhere to their prescribed treatment plans and 
appointment schedules.
Adherence to glaucoma treatment has been 
widely studied in medicine (12–25), but these 
studies have focused only on medication. In 
reality, patients also must adhere to other health 
regimens, not just medication. In the field of 
Nursing Science, adherence has a definition 
which means more than simply taking prescribed 
medications, but there are fewer studies that use 
this approach (5,26). In this study, treatment 
adherence is defined as a patient’s responsible, 
intentional and active role in self-care to maintain 
his/her health in collaboration with health care 
personnel (27). According to previous studies, 
as many as half of people with glaucoma who 
use medication do not follow their physician’s 
instructions, and 20% of them do not show up 
for the follow-up visit (1,28,29). Lunnela, Kyngäs 
and Hupli (5) point out that 58% of people with 
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glaucoma adhered well to their care, and 70% 
adhered well to their medical care. The reason 
for failure to use eyedrops might be forgetful-
ness (17), inadequate information or simple the 
inability to correctly administer the medication 
(30,31). Typical reasons for not showing up for 
the follow-up visit are that the patient does not 
perceive the illness as being that serious and the 
cost of the examination being too high (20). 
Earlier studies (5,32–34) have indicated that 
the factors connected to treatment adherence 
include the motivation to take care of oneself, 
good energy levels, support from physicians, 
nurses, relatives and friends, a sense of normality, 
positive consequences from treatments and not 
fearing complications. In contrast, it is known 
that lack of motivation and lack of support are 
connected to poor treatment adherence. In 
addition, if patients are not aware of the conse-
quences of treatment (or how leaving the disease 
untreated will affect their quality of life) it can 
lead to a careless attitude towards self-care and 
to poor adherence.   Ways to improve the moti-
vation of people with glaucoma to adhere to 
treatment include effective patient education 
provided by nurses and by devoting adequate 
time to patient education (26,35,36). People 
with glaucoma receive education and informa-
tion from their ophthalmologist (37), from liter-
ature and from nurses (5).
The aim of this study was to produce knowl-
edge that could be used to develop effective 
interventions to improve treatment adherence. 
The research questions were:
1.  How do people with glaucoma adhere to 
care?
2.  Which factors are connected to adherence of 
people with glaucoma? 
MATERIAL  AND METHODS
Questionnaire
Because the valid and reliable Adherence Instru-
ment (ACDI), developed and tested by Kyngäs 
(5,27,38), was available, there was no reason 
to develop a new questionnaire for this study. 
For the study, the questionnaire was pretested 
by people with glaucoma (n=97) to examine its 
utility. Before pretesting, some modifications 
were made to the questionnaire to make it more 
suitable for people with glaucoma; for example, 
the item concerning support from parents was 
changed to support from relatives and friends. 
Because it was likely  that some respondents 
might have impaired vision, a large font size 
in bold was used (Arial 14), and colours were 
chosen so that the contrasts were as clear as 
possible (39). Reliability was evaluated using 
Cronbach alpha values, which showed reli-
ability ranging from poor to excellent (between 
0.04 to 0.85) (5). The lowest Chronbach alpha, 
0.04, is poor. That sum variable had only 2 items 
and the internal consistency of those items was 
not good. 
The final pretested version of the question-
naire consisted of 13 demographic questions 
and 33 items on the following topics: adherence 
(medical care, responsibility, care-planning 
and carrying out care) and factors connected to 
adherence (support from physicians and nurses, 
sense of normality, support from relatives and 
friends, motivation and energy, consequences 
of treatments and fear of vision loss). The ques-
tionnaire was formatted using 5-point Likert 
scales ranging from strong agreement through 
indecision to strong disagreement.
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Data collection
A total of 513 questionnaires were distributed 
and 262 were returned, the response rate being 
51%. However, 13 questionnaires were disquali-
fied because they were inadequately completed. 
Finally, 249 questionnaires were analysed. The 
data were collected between July 2006 and 
October 2007. 
A sample of 249 adults with a diagnosis of 
glaucoma was recruited to participate in this 
cross-sectional study. These people visited the 
central hospital outpatient clinic or a private 
ophthalmologist (a purchased service paid for 
by the central hospital) in southern Finland. The 
criteria for inclusion were a minimum age of 
18, use of glaucoma medication and capability 
to answer in Finnish. Long-term hospitalization 
was an exclusion criterion. 
The researcher chose the eligible participants 
who met the criteria on the basis of referrals. 
The questionnaire, cover letter and an envelope 
with the return address were mailed along with 
the appointment card to the people selected. The 
subjects mailed the completed questionnaire 
in a sealed envelope to the IT service provider 
(a Finnish company specializing in health care 
quality development), and the provider entered 
the data into the database. This study was 
conducted in collaboration with the company 
in question. The data could only be accessed 
through hospital computers by the researcher. 
Participants
The mean age of the participants was 66 years (MD 
68, SD 11.9), ranging from 23 to 92 years. Most 
of participants were female (66%). Thirty-seven 
percent had had glaucoma for less than 3 years 
and 32% for more than 9 years. About half (52%) 
felt that glaucoma adversely effects everyday life. 
Most participants (97%) received information 
from their ophthalmologist (Table I).
Data analysis
The data were analysed with the Statistical 
Package for the Social Sciences 15 (SPSS 15) soft-
ware for Windows. Missing values were replaced 
Table I. Descriptive statistics for participants (n=249).
Characteristic n n (%)
Gender 249 
 Female  165 (66%)
 Male  84 (34%)
Age 249 
 ≤ 61 years  84 (34%)
 62–73  86 (34%)
 >73  79 (32%)
Duration of illness 248 
 ≤ 3 years  91 (37%)
 4–9  78 (31%)
 > 9  79 (32%)
Adverse effects on everyday life 240 
 yes  126 (52%)
 no  114 (48%) 
Received information 249a 
 ophthalmologist  241 (97%)
 nurse  35 (14%)
 optician  16 (6%)
 literature  76 (30%)
 the Internet  43 (17%)
 no information  1 (0.4%)
a Respondents were able to choose more than one alternative.
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with each item’s mean value. In order to verify 
the construct validity of the questionnaire and 
format sum variables, factor analysis was carried 
out. Principal component analysis (PCA) yielded 
a 10-factor solution. These factors explained 
65% of total variance. No items were deleted 
because communalities in all items were good 
(>0.30). Three items loaded on 2 factors each and 
they were placed in most consistent factors. The 
factor loading of all variables was 0.40 or higher, 
meaning that the variable will load strongly on a 
particular factor (40).
Sum variables were formatted based on factor 
analysis and named according to the contents of 
factors. Two variables which were not loaded on 
factors were analysed separately. The sum varia-
bles (SUM1–8) had at least 2 items. Factors meas-
uring treatment adherence were named adherence 
to medical care (SUM5), responsibility (SUM6), 
care-planning (SUM8) and carrying out the care 
(variable 3), and a sum variable of good adher-
ence (SUM9) was formed of these factors. Factors 
measuring connection to adherence were named 
support from nurses and physicians (SUM1), 
sense of normality (SUM2), support from rela-
tives and friends (SUM3), motivation and energy 
(SUM4), consequences of treatments (SUM7) 
and fear of vision loss (variable 33) (Table II). 
Sum variables and single variables were catego-
rized into 2 categories based on the assumption of 
earlier studies (5,38) that when answering “totally 
agree” (5 points) or “partly agree” (4 points) the 
respondent was considered to be very adherent. 
Factors related to adherence were analysed 
by cross-tabulating the categorized sum variable 
good adherence (SUM9) with demographic data 
and other categorized sum variables (SUM1-8) as 
well as with 2 single and categorized variables, 3 
and 33. In a chi-square test the significance was 
p<0.05 (40,41).
Reliability and validity
The questionnaire was used and tested previously 
in a pilot study (5). According to these tests, the 
structural validity and internal consistency were 
good (38). Before the pretesting of the question-
Table II. Cronbach’s alpha values related to sum variables of adherence and factors connected to it. 
Sum variable Number of variables Cronbach’s alpha
Sum variables of adherence
SUM5  
Adherence to medical care 3 0.507
SUM6  
Responsibility 2 0.209
SUM8  
Care-planning 3 0.379
SUM9  
Adherence to care 9 0.418
Sum variables of factors connecting adherence
SUM1  
Support from nurses and physicians 8 0.884
SUM2  
Sense of normality 6 0.586
SUM3  
Support from relatives and friends 3 0.795
SUM4  
Motivation and energy 4 0.625
SUM7  
Consequences of treatments 2 0.176
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naire, 10 patients with glaucoma and 4 ophthalmic 
nurses filled the questionnaire to ensure content 
validity. Based on the feedback, no changes were 
made to the questions (5).
Here the construct validity of the question-
naire was tested by PCA, which is generally used 
to ensure construct validity. PCA produced a factor 
solution with good statistical values, which was very 
similar to the earlier studies where the question-
naire was used. Therefore,  the construct validity 
of the questionnaire was high. However, there are 
some problems with reliability concerning internal 
consistency, which was evaluated by Cronbach 
alpha values of each sum variable (Table II). Most 
of the alpha values were good. Views on the accept-
ability of alpha coefficients vary. Nunnally (42) 
considers .60 acceptable for survey research, while 
DeVellis (43) argues that coefficients below .60 are 
unacceptable, between .60 and .65 undesirable, 
between .65 and .70 minimally acceptable, between 
.70 and .80 respectable and between .80 and .90 
very good. Low alpha values indicate that the items 
in the sum variables SUM6 and SUM7 (both with 
only 2 items) and SUM8 do not exactly measure 
the same issue (40,44). Study organizers considered 
combining these sum variables with other sum 
variables, but their contents did not match. Factor 
loadings of those items were also high, indicating 
that they belonged to sum variables 6 to 8. 
Ethical considerations
Permission to carry out this study was granted by 
the hospital director and the Ethics Committee for 
Gynaecology and Obstetrics, Otology, Ophthal-
mology, Neurology and Neurosurgery. The prin-
ciples of the Helsinki Declaration were followed 
(45). Subjects were given a cover letter stating 
the aim of the study. They were also informed 
that participation was voluntary and that either 
taking part in the study or choosing not to would 
have no impact on their treatment. Answering 
the questionnaire was considered a voluntary 
consent. Issues of confidentiality were taken into 
account at the hospital, resulting in a database 
that could only be accessed by the researcher. The 
results of the study have been reported honestly. 
The research material will be obtained, used and 
stored according to the authors’ host university 
information management regulations. Regula-
tions will be adhered to and all data collected from 
participants will be stored, used and destroyed 
according to regulations. 
RESULTS
Adherence of people with glaucoma
Almost all 242 (97%) respondents showed good 
adherence to medical care (SUM5), while only 
3% (n=7) showed poor adherence to medical care. 
Nearly all (91%, n=226) showed good responsi-
bility in their self-care (SUM6). Only 26% (n=66) 
of those with glaucoma made plans (SUM8) for 
their self-care. More than half (59%, n=148) 
carried out their care in spite of the side effects of 
eye medication. Sixty-seven percent (67%, n=166) 
of patients with glaucoma showed good adher-
ence to care (Table III).
Factors connected to adherence
More than half of the women with glaucoma 
adhered well to treatment (69%, n=114), as did 
62% of men (n=52). Most patients with glau-
coma who adhered well were found in the 62–73 
year-old age group (74%, n=64), while those with 
the poorest adherence (41%, n=34) were seen in 
the youngest age group (≤61 years). More than 
half of the very adherent people with glaucoma 
(66%, n=83) expressed their own feelings of the 
disease having an adverse effect on everyday life. 
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Table IV. Factors connected to adherence of care.
  Total Adherent Poorly adherent p
  (n= 249) (n= 166) (n= 83) (x²)
  n n (% of total) n (% of total) 
Demographic factors
Gender    
 Women 165 114 (69) 51 (31) 
     0.160
 Men 84 52 (62) 32 (38) 
Age    
 ≤ 61 84 50 (59) 34 (41) 
 62–73 86 64 (74) 22 (26) 0.118
 > 73 79 52 (66) 27 (34) 
Adverse effects on everyday life    
 high 126 83 (66) 43 (34) 
     0.503
 low 114 76 (67) 38 (33) 
Duration of illness (years)    
 ≤ 3 91 61 (67) 30 (33) 
 4–9 78 54 (69) 24 (31) 0.727
 > 9 79 50 (63) 29 (37) 
Information source    
 Physician or nurse 246  163 (66) 83 (34) 0.295
 Other sources 117  81 (69) 36 (31) 0.251
Factors connected to adherence of care
 Support from nurses and physicians (SUM1) 249 126 (51) 123 (49) <0.001
 Sense of normality (SUM2) 249 154 (62) 95 (38) 0.712
 Support from relatives and friends (SUM3) 249 150 (60) 99 (40) 0.170
 Motivation and energy (SUM4) 249 230 (92) 19 (8) 0.177
 Consequences of treatments (SUM7) 249 217 (87) 32 (13) 0.003
 Fear of vision loss    
    afraid 226 152 (67) 74 (33) 
     0.536
    not afraid  23 14 (61)  9 (39) 
Adherence of people with glaucoma 
However, almost as many very adherent people 
with glaucoma did not experience adverse effects 
in everyday life (67%, n=76). Those who had had 
the illness for 4–9 years were the most adherent 
to treatment (69%, n=54), while those who had 
had the illness for more than 9 years (37%, n=29) 
showed the poorest adherence. Sixty-six percent 
(66%, n=163) of people with glaucoma who had 
received information from physicians and nurses 
were very adherent. Very adherent people with 
glaucoma had also received information from 
other sources (69%, n=81), such as opticians, 
leaflets, literature and the Internet. There was 
no statistically significant connection between 
Table III. Adherence of people with glaucoma.
 Total Good adherence Poor adherence
 n n (%) n (%)
Adherence to medical care 249  242 (97 %) 7 (3 %)
SUM5    
Responsibility 249 226 (91 %) 23 (9 %)
SUM6   
Care-planning 249 66 (26 %) 183 (74 %) 
SUM8   
Carrying out the care 249 148 (59 %) 101 (41 %)
Variable 3   
Adherence to care 249 166 (67 %) 83 (33 %)
SUM9   
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background variables and the factors connected 
to adherence.
Half of the people with glaucoma who 
adhered well to treatment (51%, n=126) had 
received support from physicians and nurses 
(SUM1). Support from physicians and nurses 
had a statistically significant connection to treat-
ment adherence (p<0.001); more than half (60%, 
n=99) of those who had received insufficient 
support were adhered well, while 67% (n=56) of 
those who had received little support  adhered 
poorly. A sense of normality (SUM2) was typical 
among people with glaucoma who adhered well 
(62%, n=154), as was support from relatives and 
friends (SUM3, 60%, n=150). However, SUM2 
(p=0.712) and SUM3 (p=0.170) did not have a 
statistically significant connection to adherence.
Very adherent people with glaucoma were 
very motivated and felt that they had an abun-
dance of energy (92%, n=230). However, only 8% 
(n=19) of poorly adherent people with glaucoma 
felt they had enough motivation and energy 
(SUM4, p=0.177). Many very adherent people 
with glaucoma experienced positive results 
from treatments. Results from treatments had a 
connection to adherence; 87% (n=217) of very 
adherent people with glaucoma experienced 
good results from treatments. Only 13% (n=32) 
of the poorly adherent people with glaucoma 
experienced positive results from treatments 
(SUM7, p=0.003). 
Fear of vision loss was very common among 
people with glaucoma. Almost all (91%, n=226) 
were afraid of losing their vision. However, fear 
of vision loss had no statistically significant 
connection to adherence since 67% (n=152) of 
very adherent people with glaucoma feared losing 
their vision because of the illness, while 33% 
(n=74) of the poorly adherent were also afraid of 
losing their vision (variable 33, p=0.536).
DISCUSSION
These results illustrate that two-thirds of people 
with glaucoma adhere well to their treatment 
plans. According to previous studies, only about 
half of people show good adherence to treatment 
plans (1,5,28,29), so it seems that people with 
glaucoma adhere better than people with other 
chronic diseases. Additionally, people in this 
study were more adherent to medical care than in 
a previous study (5). This is remarkable, because 
one of the most important aspects of glaucoma 
management is regular eyedrop administration 
(2). However, it is essential to consider whether 
respondents answered the items on medication 
honestly or whether they responded in the way 
they knew they should. Regardless, most patients 
had fears of vision loss, and this may have been 
sufficient motivation to use eyedrops as recom-
mended. People with glaucoma have reported that 
the illness has adverse effects on their lives (4), but 
also opposite findings have been demonstrated 
(7). In this study most of the glaucoma patients 
were afraid of vision loss as was also indicated by 
Odberg (4). This illustrates the fact that they were 
quite well aware of the functional and structural 
abnormalities caused by glaucoma (1).
Based on earlier studies, it is known that moti-
vation is a very important factor connected to 
good adherence to a treatment plan (5,32–34). 
This result was not as clearly indicated in the 
present study. However, people with glaucoma 
appeared to be responsible and well motivated to 
take care of themselves, they were relatively active 
and their collaboration with health care personnel 
was good, as also indicated by previous studies 
(5,32–34). Arguably, patients are unable to assume 
full responsibility for their care if they do not 
have the necessary knowledge and skills as well 
as the requisite mental readiness. In light of this, 
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patient support and education is very important 
for improving patients’ adherence to their health 
regimens and their willingness to assume respon-
sibility for that care (26,35,36). 
Patients expect to get support from health care 
providers. According to this study, more than half 
of those who had received support and patient 
education adhered well to their treatment plans, 
and correspondingly, more than half of those who 
had not received support or patient education 
were poorly adherent. Based on this finding, it 
can be concluded that receiving proper informa-
tion and patient education leads to better treat-
ment adherence. This is also supported by earlier 
studies (26,32,33,35,36). However, this is a big 
challenge for doctors and specialists in northern 
Finland as well as in other sparsely populated 
areas. In Lapland in northern Finland, the need 
for patient education is high because of the high 
prevalence of glaucoma. Despite this, the number 
of ophthalmologists is lower than those residing in 
southern Finland. In addition, northern Finland is 
very sparsely populated. Only 3.5% of the Finnish 
population live there, and the average population 
density is 2 people per square kilometre. These 
conditions pose a challenge to providing adequate 
patient education and support. Computer-based 
interventions may help, but there have been 
contradicting findings as to whether these are 
effective or not. 
Knowledge of consequences of treatment had 
a statistically significant connection to treatment 
adherence. This is supported by earlier studies 
(5,32–34). If patients are made well aware of the 
consequences of treatments (or the lack of treat-
ment), they know why they have to follow the 
instructions given by health care providers. In that 
case, their actions are reasonable and lead to posi-
tive effects. It is necessary for them to know both 
why and how they have to follow the instructions 
provided. They also need to have the proper skills 
to carry out treatments (5,32). 
There are some limitations in this research. 
First, the response rate was only 51%. This is better 
than the usual response rate for mailed ques-
tionnaires (25–30%) (41); nevertheless, the low 
response rate might indicate poor treatment adher-
ence among people with glaucoma, since poorly 
adherent people do not answer questionnaires of 
this kind. When studying treatment adherence, 
it is essential to recognize that subjects are giving 
their own estimate of their adherence, which may 
not be an accurate reflection of reality. However, 
there is no other way to measure treatment adher-
ence. According to earlier studies (5,38), poorly 
adherent people give a better impression of their 
adherence than what is actually the case. It was 
mentioned in the cover letter that there are no 
right or wrong answers and that respondents are 
supposed to answer according to the way things 
are in their lives, not as they would like them to 
be. This statement might lead people to provide 
answers that they think are “good” or “appropriate” 
instead of accurate. However, these results support 
the earlier findings of the pilot study by Lunnela et 
al. (5), so it can be concluded that the results of this 
study are valid.
Second, in terms of technical implementa-
tion, the possible vision loss of respondents was 
taken into consideration by using a large and clear 
font and good contrast in the questionnaire (39). 
However, the instructions in the cover letter were 
not clear enough and that might have decreased 
the validity. This weakness was indicated in many 
items that were not answered, although indecision 
was also a possible reason for unanswered items.
Third, the support from relatives and friends 
was crucial for treatment adherence because 
almost two-thirds of those who had received 
support from relatives and friends showed good 
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adherence. As most of the respondents were elderly 
(MD 68 years), it can be considered that many 
elderly people may receive support from their rela-
tives for other reasons as well, such as for other 
illnesses (30,31). Indications of this did not appear 
in the study, because the respondents were not 
asked about other illnesses. When studying elderly 
people it is perhaps more reasonable to examine 
their life situations in a holistic way, taking other 
illnesses and the surrounding environment into 
consideration. However, it can be concluded that 
the respondents were in relatively good health, 
because no long-term hospitalized respondents 
were included in this study. 
Fourth, this study was conducted in southern 
Finland. The prevalence of glaucoma is higher 
in northern Finland (Lapland has an average of 
47), where it is more difficult to visit an ophthal-
mologist because of the great distances patients 
are required to travel. It would be very important 
to study if those great distances are connected to 
adherence of people with glaucoma living there. 
Adherence of people with glaucoma has not been 
studied much in other Nordic countries. It would 
be interesting to investigate and compare people 
living in those areas. As well, there are no studies 
concerning the role of telemedicine in glaucoma 
treatment. That would also be a very interesting 
subject to study.
In summary, these results indicate that nurses 
and physicians play a very important role in 
providing patient education and support. In prac-
tice, it is crucial to at least maintain this level 
of access to information by developing more 
tailored and time-saving education and support 
methods. It is even more important to identify 
poorly adherent patients with glaucoma as early 
as possible to increase their adherence not only 
to properly taking their medication but also to 
follow-up visits and self-care. However, a more 
holistic attitude that involves discussing patients’ 
care with them and including them in the deci-
sion-making process is required from health care 
personnel. The findings of this study are useful 
in developing patient education and support 
methods for people with glaucoma.
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